- ￥10300
- MATRiKs Biotek
- 土耳其
- INF-QLS-REMI
- 2025年08月29日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 库存：
5
- 供应商：
西宝生物400-021-8158
- 规格：
96T
Enzyme immunoassay for the qualitative determination of antibodies to Infliximab (Remicade®) in serum and plasma.
This kit has been especially developed for the qualitative antibodies to infliximab in serum and plasma samples
Infliximab (Remicade) was associated to the development of anti-Infliximab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Remicade®. This might lead to severe complications. The Matriks Biotek shikari® Antibody to Infliximab ELISA Kit can be efficiently used for monitoring anti-Infliximab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-Infliximab antibodies.
All SHIKARI® ELISA kits are suitable for biosimilar work.
All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
